CDH1 and breast cancer: Later, a study conducted on 226 pT1 HG BC from TUR confirmed the association of aberrant E-cadherin expression and progression (p= 0.045) and showed the same trend at multivariate analysis (HR 0.45, CI 0.19–1.06, p = 0.068) (62).